Rezolute, Inc. (RZLT)
4.87
+0.23
(+4.96%)
USD |
NASDAQ |
Oct 09, 16:00
4.86
-0.01
(-0.21%)
After-Hours: 20:00
Rezolute Price : 4.87 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 4.60 | 4.91 | 4.55 | 4.87 | 1.874M |
| Oct 08, 2026 | 4.33 | 4.685 | 4.32 | 4.64 | 2.198M |
| Oct 07, 2026 | 4.29 | 4.56 | 4.23 | 4.38 | 1.690M |
| Oct 06, 2026 | 4.64 | 4.64 | 4.150 | 4.32 | 2.192M |
| Oct 05, 2026 | 4.05 | 4.535 | 3.820 | 4.33 | 4.198M |
| Oct 02, 2026 | 4.13 | 4.20 | 3.965 | 4.01 | 1.646M |
| Oct 01, 2026 | 4.14 | 4.175 | 4.04 | 4.07 | 981719.0 |
| Sep 30, 2026 | 4.19 | 4.345 | 4.135 | 4.14 | 1.703M |
| Sep 29, 2026 | 4.545 | 4.57 | 4.07 | 4.09 | 1.519M |
| Sep 28, 2026 | 3.85 | 4.195 | 3.76 | 4.18 | 1.588M |
| Sep 25, 2026 | 3.99 | 4.05 | 3.871 | 3.90 | 2.047M |
| Sep 24, 2026 | 4.03 | 4.085 | 3.835 | 3.94 | 3.869M |
| Sep 23, 2026 | 4.05 | 4.13 | 3.98 | 4.00 | 1.683M |
| Sep 22, 2026 | 3.96 | 4.09 | 3.95 | 4.04 | 928648.0 |
| Sep 21, 2026 | 3.84 | 3.93 | 3.73 | 3.91 | 1.083M |
| Sep 18, 2026 | 3.95 | 3.95 | 3.665 | 3.84 | 2.527M |
| Sep 17, 2026 | 4.09 | 4.14 | 3.885 | 3.95 | 1.837M |
| Sep 16, 2026 | 4.20 | 4.23 | 3.875 | 3.98 | 2.047M |
| Sep 15, 2026 | 4.28 | 4.28 | 4.11 | 4.15 | 752979.0 |
| Sep 14, 2026 | 4.18 | 4.28 | 4.09 | 4.25 | 828034.0 |
| Sep 11, 2026 | 4.23 | 4.355 | 4.08 | 4.22 | 1.353M |
| Sep 10, 2026 | 4.03 | 4.35 | 3.97 | 4.17 | 2.225M |
| Sep 09, 2026 | 4.55 | 4.55 | 4.02 | 4.06 | 2.074M |
| Sep 08, 2026 | 4.51 | 4.53 | 4.37 | 4.40 | 867085.0 |
| Sep 04, 2026 | 4.49 | 4.62 | 4.44 | 4.58 | 716948.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 276.47 |
| Avalo Therapeutics, Inc. | 13.65 |
| Opus Genetics, Inc. | 4.65 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.68 |
Price Related Metrics
| Price to Book Value | 4.663 |
| Earnings Yield | -15.33% |
| Market Cap | 469.50M |